Intelicare Holdings Past Earnings Performance
Past criteria checks 0/6
Intelicare Holdings's earnings have been declining at an average annual rate of -1.2%, while the Healthcare Services industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 5.3% per year.
Key information
-1.2%
Earnings growth rate
24.2%
EPS growth rate
| Healthcare Services Industry Growth | 42.6% |
| Revenue growth rate | 5.3% |
| Return on equity | n/a |
| Net Margin | -795.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Intelicare Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -2 | 2 | 0 |
| 31 Mar 24 | 0 | -2 | 2 | 0 |
| 31 Dec 23 | 0 | -1 | 2 | 0 |
| 30 Sep 23 | 0 | -2 | 2 | 0 |
| 30 Jun 23 | 0 | -3 | 2 | 0 |
| 31 Mar 23 | 0 | -4 | 2 | 0 |
| 31 Dec 22 | 0 | -4 | 2 | 0 |
| 30 Sep 22 | 0 | -4 | 2 | 0 |
| 30 Jun 22 | 0 | -4 | 2 | 0 |
| 31 Mar 22 | 0 | -4 | 3 | 0 |
| 31 Dec 21 | 0 | -5 | 3 | 0 |
| 30 Sep 21 | 0 | -5 | 3 | 0 |
| 30 Jun 21 | 0 | -4 | 3 | 0 |
| 31 Mar 21 | 0 | -3 | 2 | 0 |
| 31 Dec 20 | 1 | -2 | 1 | 0 |
| 30 Sep 20 | 0 | -2 | 1 | 0 |
| 30 Jun 20 | 0 | -3 | 1 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 1 |
| 30 Jun 18 | 0 | 0 | 0 | 0 |
Quality Earnings: ICR is currently unprofitable.
Growing Profit Margin: ICR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ICR is unprofitable, and losses have increased over the past 5 years at a rate of 1.2% per year.
Accelerating Growth: Unable to compare ICR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ICR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.9%).
Return on Equity
High ROE: ICR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.